STOCK TITAN

HRT Financial (SHPH) reports mixed SHPH share trades in Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Shuttle Pharmaceuticals Holdings, Inc. reported that significant shareholder HRT Financial LP made offsetting trades in its common stock. On July 2, HRT Financial LP executed an open-market purchase of 7,851 shares at $3.54 per share. On July 6, it executed an open-market sale of 9,022 shares at $3.51 per share, resulting in a modest net reduction of its position. Following these transactions, HRT Financial LP directly held 81,385 shares of Shuttle Pharmaceuticals common stock.

Positive

  • None.

Negative

  • None.
Insider HRT FINANCIAL LP
Role null
Bought 7,851 shs ($28K)
Sold 9,022 shs ($32K)
Type Security Shares Price Value
Sale Common Stock 9,022 $3.51 $32K
Purchase Common Stock 7,851 $3.54 $28K
Holdings After Transaction: Common Stock — 81,385 shares (Direct, null)
Footnotes (1)
Shares purchased 7,851 shares Open-market purchase at $3.54 on July 2
Purchase price $3.54 per share Common stock open-market purchase on July 2
Shares sold 9,022 shares Open-market sale at $3.51 on July 6
Sale price $3.51 per share Common stock open-market sale on July 6
Net share change -1,171 shares Net of reported buys and sells
Shares owned after 81,385 shares Direct common stock holdings following transactions
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
ten percent owner financial
""is_ten_percent_owner": 1"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider activity did HRT Financial LP report for Shuttle Pharmaceuticals (SHPH)?

HRT Financial LP reported both buying and selling SHPH shares. It purchased 7,851 common shares at $3.54 and sold 9,022 shares at $3.51 in open-market trades, resulting in a small net decrease in its holdings.

How many Shuttle Pharmaceuticals (SHPH) shares does HRT Financial LP own after these trades?

HRT Financial LP directly owns 81,385 SHPH common shares after the trades. This figure reflects its position following the July 2 purchase of 7,851 shares and the July 6 sale of 9,022 shares reported in the Form 4.

Did HRT Financial LP have a net buy or net sell of SHPH shares in this Form 4?

The activity resulted in a net sale of SHPH shares. HRT Financial LP bought 7,851 shares and sold 9,022 shares, for a net reduction of 1,171 common shares in its reported position.

At what prices did HRT Financial LP trade Shuttle Pharmaceuticals (SHPH) shares?

HRT Financial LP traded SHPH shares around the mid-$3 range. It reported an open-market purchase at $3.54 per share and an open-market sale at $3.51 per share, reflecting closely priced transactions over several days.

Is HRT Financial LP a major shareholder of Shuttle Pharmaceuticals (SHPH)?

HRT Financial LP is identified as a ten percent owner of SHPH. The Form 4 indicates this status, meaning it is considered a significant shareholder while directly holding 81,385 common shares after the reported transactions.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HRT FINANCIAL LP

(Last)(First)(Middle)
3 WORLD TRADE CENTER, 175 GREENWICH STRE
76TH FLOOR

(Street)
NEW YORK NEW YORK 10007

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Shuttle Pharmaceuticals Holdings, Inc. [ SHPH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/02/2026P7,851A$3.5490,407D
Common Stock07/06/2026S9,022D$3.5181,385D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Adam Nunes07/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)